APA

Wang P., Quan Z., Luo D., Chen W. & Peng D. (20190801). Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1. : Molecular medicine reports.

Chicago

Wang Ping, Quan Zhengli, Luo Dingshi, Chen Wangshan and Peng Dan. 20190801. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1. : Molecular medicine reports.

Harvard

Wang P., Quan Z., Luo D., Chen W. and Peng D. (20190801). Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1. : Molecular medicine reports.

MLA

Wang Ping, Quan Zhengli, Luo Dingshi, Chen Wangshan and Peng Dan. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1. : Molecular medicine reports. 20190801.